Impact of Guided Care With the Vectra DA Multi-biomarker Disease Activity (MBDA) Blood Test

  • STATUS
    Recruiting
  • days left to enroll
    53
  • participants needed
    500
  • sponsor
    Myriad Genetic Laboratories, Inc.
Updated on 13 December 2020
Investigator
Jacob Demos
Primary Contact
Lifebridge Sinai Hospital of Baltimore (7.7 mi away) Contact
+10 other location
DMARD

Summary

Nine months multi-center prospective, randomized observational study, two arm trial to evaluate the effect of MBDA score-guided care on disease activity and medical costs.

Description

Nine months multi-center prospective, randomized observational study, two arm trial to evaluate the effect of MBDA score-guided care on disease activity and medical costs. To investigate whether treatment decisions guided by MBDA scores result in reduced disease activity and overall medical cost among patients with RA relative to usual care (UC).

Details
Treatment Vectra DA MBDA Test
Clinical Study IdentifierNCT03810144
SponsorMyriad Genetic Laboratories, Inc.
Last Modified on13 December 2020

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 18 yrs?
Gender: Male or Female
Do you have any of these conditions: Rheumatoid Arthritis (Pediatric) or Rheumatoid Arthritis?
Do you have any of these conditions: Rheumatoid Arthritis or Rheumatoid Arthritis (Pediatric)?
Do you have any of these conditions: Rheumatoid Arthritis or Rheumatoid Arthritis (Pediatric)?
Willing and able to sign an informed consent form (ICF)
Age at least 18 years old at screening visit
Diagnosed with RA according to 1987 or 2010 criteria of the American College of Rheumatology
Actively managed by a CareFirst health care practitioner
Currently taking one or more biologic and/or non-biologic DMARDs listed in Appendix 2
Currently has CareFirst medical coverage

Exclusion Criteria

Active infection
History of malignancy within the past 5 years or any evidence of persistent malignancy, except fully excised basal cell or squamous cell carcinomas of the skin, or cervical carcinoma in situ that has been treated or excised in a curative procedure
Current enrollment in another clinical trial
On non-biologic DMARD monotherapy or combination therapy with stable disease for 6 months
Any condition or circumstance that makes it likely the patient will not be able to complete the 9-month trial
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.
Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more
Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more
Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study

user name

Annotated by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No made yet